Streptavidin: A Novel Immunostimulant for the Selection and Delivery of Autologous and Syngeneic Tumor Vaccines

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-13-0157
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Development of Streptavidin-Based Nanocomplex for siRNA Delivery

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2013English

A Device for the Targeting Delivery of Particulate DNA Vaccines

Biotechnology
BiochemistryGeneticsMolecular Biology
2006English

Autologous Heat-Shock Protein Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

A Novel Technique for Database Selection and Document Selection

International Journal of Computer Applications
2011English

Alternative Administration Routes and Delivery Technologies for Polio Vaccines

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Selection of a Novel CD19 Aptamer for Targeted Delivery of Doxorubicin to Lymphoma Cells

Oncotarget
Oncology
2018English

Selective in Vivo Imaging of Syngeneic, Spontaneous, and Xenograft Tumors Using a Novel Tumor Cell-Specific Hsp70 Peptide-Based Probe

Cancer Research
Cancer ResearchOncology
2014English

Delivery Systems for Gene-Based Vaccines

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2000English

Introduction: Strengthening the Delivery of New Vaccines for Adolescents

Pediatrics
Child HealthPediatricsPerinatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy